(PATH) Uipath - Overview
Sector: Technology | Industry: Software - Infrastructure | Exchange: NYSE (USA) | Market Cap: 5.856m USD | Total Return: -11.8% in 12m
Industry Rotation: -27.5
Avg Turnover: 254M USD
Peers RS (IBD): 40.8
EPS Trend: 69.3%
Qual. Beats: 1
Rev. Trend: 89.1%
Qual. Beats: 4
Warnings
Altman Z'' -0.46 < 1.0 - financial distress zone
Volatile
Tailwinds
Garp
UiPath Inc. (PATH) operates as a global leader in the robotic process automation (RPA) sector, providing an end-to-end platform designed to automate repetitive business tasks. The company’s software robots utilize artificial intelligence (AI), machine learning (ML), and natural language processing (NLP) to emulate human actions across user interfaces and APIs. This technology is primarily deployed through the Automation Cloud, which reduces infrastructure overhead for enterprise clients.
The business model follows a software-as-a-service (SaaS) structure, focusing on high-growth industries such as financial services, healthcare, and manufacturing. Within the Systems Software sub-industry, RPA tools are increasingly integrated with process mining capabilities, which allow organizations to analyze digital footprints to identify inefficiencies before deploying automation. This integration of AI and low-code functionality aims to enhance productivity by enabling seamless collaboration between human workers and digital assistants.
Headquartered in New York and founded in 2005, the company maintains a significant international presence with major operations in Romania and the United Kingdom. Investors looking for deeper fundamental insights may find further value in exploring the analysis available at ValueRay. The platform’s analytics suite also includes performance tracking and predictive insights to help organizations measure the return on investment for their automation deployments.
- Enterprise adoption of automation software drives recurring revenue growth
- AI and ML integration enhances platform capabilities and customer value
- Competition from established software vendors impacts market share
- Economic downturns reduce IT spending and automation project budgets
- Regulatory scrutiny on data privacy and AI ethics increases compliance costs
| Net Income: 282.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 0.41 > 1.0 |
| NWC/Revenue: 83.11% < 20% (prev 107.7%; Δ -24.58% < -1%) |
| CFO/TA 0.12 > 3% & CFO 371.2m > Net Income 282.3m |
| Net Debt (-1.39b) to EBITDA (74.8m): -18.59 < 3 |
| Current Ratio: 2.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (545.3m) vs 12m ago -1.82% < -2% |
| Gross Margin: 83.25% > 18% (prev 0.83%; Δ 8.24k% > 0.5%) |
| Asset Turnover: 53.29% > 50% (prev 49.90%; Δ 3.39% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
| A: 0.42 (Total Current Assets 2.24b - Total Current Liabilities 905.4m) / Total Assets 3.18b |
| B: -0.54 (Retained Earnings -1.71b / Total Assets 3.18b) |
| C: 0.02 (EBIT TTM 57.9m / Avg Total Assets 3.02b) |
| D: -1.52 (Book Value of Equity -1.67b / Total Liabilities 1.10b) |
| Altman-Z'' Score: -0.46 = B |
| DSRI: 0.95 (Receivables 580.7m/542.3m, Revenue 1.61b/1.43b) |
| GMI: 0.99 (GM 83.25% / 82.69%) |
| AQI: 1.74 (AQ_t 0.26 / AQ_t-1 0.15) |
| SGI: 1.13 (Revenue 1.61b / 1.43b) |
| TATA: -0.03 (NI 282.3m - CFO 371.2m) / TA 3.18b) |
| Beneish M-Score: -2.57 (Cap -4..+1) = A |
Over the past week, the price has changed by -15.87%, over one month by -19.07%, over three months by -45.59% and over the past year by -11.76%.
- StrongBuy: 3
- Buy: 1
- Hold: 18
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 13.8 | 47.2% |
P/E Forward = 13.5501
P/S = 3.6357
P/B = 2.8277
P/EG = 0.3869
Revenue TTM = 1.61b USD
EBIT TTM = 57.9m USD
EBITDA TTM = 74.8m USD
Long Term Debt = 81.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = unknown (none)
Debt = 81.2m USD (corrected: LT Debt 81.2m + ST Debt none)
Net Debt = -1.39b USD (recalculated: Debt 81.2m - CCE 1.47b)
Enterprise Value = 4.46b USD (5.86b + Debt 81.2m - CCE 1.47b)
Interest Coverage Ratio = unknown (Ebit TTM 57.9m / Interest Expense TTM 0.0)
EV/FCF = 12.68x (Enterprise Value 4.46b / FCF TTM 352.2m)
FCF Yield = 7.89% (FCF TTM 352.2m / Enterprise Value 4.46b)
FCF Margin = 21.87% (FCF TTM 352.2m / Revenue TTM 1.61b)
Net Margin = 17.53% (Net Income TTM 282.3m / Revenue TTM 1.61b)
Gross Margin = 83.25% ((Revenue TTM 1.61b - Cost of Revenue TTM 269.8m) / Revenue TTM)
Gross Margin QoQ = 84.88% (prev 83.26%)
Tobins Q-Ratio = 1.40 (Enterprise Value 4.46b / Total Assets 3.18b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 81.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = 45.7m (EBIT 57.9m * (1 - 21.00%))
Current Ratio = 2.48 (Total Current Assets 2.24b / Total Current Liabilities 905.4m)
Debt / Equity = 0.04 (Debt 81.2m / totalStockholderEquity, last quarter 2.08b)
Debt / EBITDA = -18.59 (Net Debt -1.39b / EBITDA 74.8m)
Debt / FCF = -3.95 (Net Debt -1.39b / FCF TTM 352.2m)
Total Stockholder Equity = 1.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.34% (Net Income 282.3m / Total Assets 3.18b)
RoE = 15.32% (Net Income TTM 282.3m / Total Stockholder Equity 1.84b)
RoCE = 3.01% (EBIT 57.9m / Capital Employed (Equity 1.84b + L.T.Debt 81.2m))
RoIC = 2.48% (NOPAT 45.7m / Invested Capital 1.84b)
WACC = 11.10% (E(5.86b)/V(5.94b) * Re(11.25%) + D(81.2m)/V(5.94b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 11.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.58%
[DCF] Terminal Value 67.80% ; FCFF base≈333.6m ; Y1≈331.3m ; Y5≈346.7m
[DCF] Fair Price = 11.40 (EV 3.84b - Net Debt -1.39b = Equity 5.23b / Shares 459.2m; r=11.10% [WACC]; 5y FCF grow -1.40% → 3.0% )
EPS Correlation: 69.33 | EPS CAGR: 147.0% | SUE: 1.56 | # QB: 1
Revenue Correlation: 89.08 | Revenue CAGR: 19.71% | SUE: 1.76 | # QB: 4
EPS next Quarter (2026-07-31): EPS=0.15 | Chg7d=+0.010 | Chg30d=+0.010 | Revisions Net=+6 | Analysts=19
EPS current Year (2027-01-31): EPS=0.80 | Chg7d=+0.036 | Chg30d=+0.036 | Revisions Net=+10 | Growth EPS=+10.9% | Growth Revenue=+9.1%
EPS next Year (2028-01-31): EPS=0.90 | Chg7d=+0.064 | Chg30d=+0.064 | Revisions Net=+12 | Growth EPS=+12.3% | Growth Revenue=+8.4%
[Analyst] Revisions Ratio: +0.43 (10 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.5% (Discount Rate 11.2% - Earnings Yield 4.7%)
[Growth] Growth Spread = +3.2% (Analyst 9.7% - Implied 6.5%)